Description
Axitinib
Each film-coated tablet contains: Axitinib … 5mg.
INDICATION
LuciAxi is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy.
DOSAGE AND USE
• The starting dose is 5 mg orally twice daily. Dose adjustments can be made based on individual safety and tolerability. • Administer LuciAxi dose approximately 12 hours apart with or without food.
STORAGE
In a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY
LUCIUS PHARMACEUTICALS(LAO) CO., LTD No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNING
Keep medicine out of reach of Children. Do not administer LuciAxi during Pregnancy and Lactation.
Reviews
There are no reviews yet.